Description
Development of a Nasal Vaccine for the prevention of coronavirus disease 2019 due to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $1,307,678 at start, $2,906,107 after amendment #3 (+$1,598,429).
- #02020-09-24$1,307,678
- #22021-03-11$1,307,678
- #32021-08-17$2,906,107+$1,598,429
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-09-24(start date) | $1,307,678 | — | Development of a Nasal Vaccine for the prevention of coronavirus disease 2019 due to infection with severe acu… |
| #2 amendment | 2021-03-11 | $1,307,678 | +$0 | Development of a Nasal Vaccine for the prevention of coronavirus disease 2019 due to infection with severe acu… |
| #3 amendment | 2021-08-17 | $2,906,107 | +$1,598,429 | Development of a Nasal Vaccine for the prevention of coronavirus disease 2019 due to infection with severe acu… |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 801344995)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2020-2021-Q3-957718 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $30,000 | FY2021 |
| 093-2019-2020-Q4-00528 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · Regional Economic Growth through Innovation Program (REGI) | $1,000,000 | FY2020 |
| 093-2021-2022-Q1-00103 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · Regional Economic Growth through Innovation Program (REGI) | $1,000,000 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q2-957294 · retrieved 2026-11-15.